| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| REPLIGEN CORP | Director | Common Stock | 2,016 | $281,090 | $139.43 | 15 May 2025 | Direct |
| REPLIGEN CORP | Director | Stock Option (Right to Buy) | 1,800 | 15 May 2025 | Direct | ||
| ALIMERA SCIENCES INC | Director | Stock Option (Right to Buy) | 0 | 16 Sep 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RGEN | REPLIGEN CORP | 15 May 2025 | 2 | $0 | 4 | Director | 19 May 2025, 14:59 |
| RGEN | REPLIGEN CORP | 17 Mar 2025 | 1 | +$37,672 | 4 | Director | 18 Mar 2025, 15:58 |
| /report/000110465924101111-pax-margaret-2024-09-16 | ALIMERA SCIENCES INC | 16 Sep 2024 | 1 | $0 | 4 | Director | 18 Sep 2024, 21:53 |
| RGEN | REPLIGEN CORP | 16 May 2024 | 2 | $0 | 4 | Director | 20 May 2024, 19:30 |
| RGEN | REPLIGEN CORP | 18 Mar 2024 | 3 | $0 | 4 | Director | 19 Mar 2024, 18:19 |
| RGEN | REPLIGEN CORP | 18 Mar 2024 | 0 | $0 | 3 | Director | 19 Mar 2024, 17:34 |
| /report/000095017023061355-pax-margaret-2023-11-07 | ALIMERA SCIENCES INC | 07 Nov 2023 | 1 | $0 | 4 | Director | 08 Nov 2023, 18:58 |
| /report/000095017023061353-pax-margaret-2023-11-07 | ALIMERA SCIENCES INC | 07 Nov 2023 | 0 | $0 | 3 | Director | 08 Nov 2023, 18:54 |